School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Beryl Manning-Geist

  • Department of Gynecology & Obstetrics
    Assistant Professor
  • beryl.manning-geist@emory.edu
  • @Doctor_Beryl
Head shot of Beryl Manning-Geist

Overview

Beryl Manning-Geist, MD, FACOG, is a board-certified gynecologic oncologist at Winship Cancer Institute of Emory University School of Medicine. Dr. Manning-Geist specializes in the treatment of gynecologic malignancies, and is an attending physician based primarily at Emory University Hospital Midtown and Emory University Hospital.

Dr. Manning-Geist is a fellow of the American College of Obstetricians and Gynecologists and has served in multiple leadership roles and committees for Society of Gynecologic Oncology, where she currently serves on the Clinical Practice Committee, NRG Oncology, where she serves on the rare tumor subcommittee and has been named as an Early Career New Investigator, and the international consortium for low grade serous ovarian cancer.

Dr. Manning-Geist completed medical school on a full merit-based Woodruff scholarship at Emory University School of Medicine, her obstetrics and gynecology residency at Harvard University's Massachusetts General Hospital and Brigham and Women's Hospital, and her gynecologic oncology fellowship at the Memorial Sloan Kettering Cancer Center in New York City, where she was awarded with the prestigious Byrd award for best surgical fellow in the Department of Surgery on graduating.

Dr. Manning-Geist co-leads the Gynecologic cancer research program at Emory University, where she focuses on novel therapeutics and targeted therapies, immunotherapies, and surgical management of endometrial and ovarian cancers. At Emory, she also serves on the Phase I clinical trial committee.

Dr. Manning-Geist serves on the editorial board of Gynecologic Oncology. She has published extensively on gynecologic cancers with over 50 peer-reviewed publications as well as several book chapters. She has numerous research-related awards including the ASCO Merit Award, Society of Gynecologic Oncology's Young Investigator Award, and the 2025 Winship Early Career Clinical Investigator Leadership Award.

Academic Appointment

  • Assistant Attending, Gynecology and Obstetrics, Emory University

Education

Degrees

  • M.D. from Emory University
  • B.A. from Williams College

Research

Publications

  • Following the folate receptor: Expanding targeted treatment options in low grade serous ovarian carcinoma.
    Gynecol Oncol Volume: 191 Page(s): A1 - A2
    12/01/2024 Authors: Thayer EG; Manning-Geist BL
  • Raising the bar on collaborative science: the SENECA study and sentinel lymph node mapping.
    Int J Gynecol Cancer Volume: 34 Page(s): 1322 - 1323
    09/02/2024 Authors: Manning-Geist BL; Mueller JJ
  • Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities.
    Gynecol Oncol Volume: 188 Page(s): 52 - 57
    09/01/2024 Authors: Manning-Geist BL; Sullivan MW; Zhou Q; Iasonos A; Selenica P; Stallworth C; Liu YL; Long Roche K; Gordhandas S; Aghajanian C
  • Redefining the standard of care for low-grade serous ovarian cancer.
    Clin Adv Hematol Oncol Volume: 22 Page(s): 205 - 226
    06/01/2024 Authors: Manning-Geist BL; Cantor T; O'Cearbhaill RE; Grisham RN
  • Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
    Int J Gynecol Cancer Volume: 34 Page(s): 697 - 704
    05/06/2024 Authors: Manning-Geist BL; Rios-Doria E; Liu YL; Ellenson LH; Zhou QC; Iasonos A; Leitao MM; Abu-Rustum NR; Weigelt B; Mueller JJ
  • Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.
    Nat Med Volume: 30 Page(s): 1330 - 1338
    05/01/2024 Authors: Friedman CF; Manning-Geist BL; Zhou Q; Soumerai T; Holland A; Da Cruz Paula A; Green H; Ozsoy MA; Iasonos A; Hollmann T
  • Update on near infrared imaging technology: indocyanine green and near infrared technology in the treatment of gynecologic cancers.
    Int J Gynecol Cancer Volume: 34 Page(s): 416 - 420
    03/04/2024 Authors: Manning-Geist B; Obermair A; Broach VA; Leitao MM; Zivanovic O; Abu-Rustum NR
  • Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.
    Cancer Volume: 130 Page(s): 576 - 587
    02/15/2024 Authors: Liu YL; Gordhandas S; Arora K; Rios-Doria E; Cadoo KA; Catchings A; Maio A; Kemel Y; Sheehan M; Salo-Mullen E
  • Trachelectomy and fertility-sparing procedures for early-stage cervical cancer: A state of the science review.
    Gynecol Oncol Volume: 181 Page(s): 179 - 182
    02/01/2024 Authors: Manning-Geist B; Grace MA; Sonoda Y
  • Fertility-sparing and minimally invasive surgery for early-stage cervical cancer.
    J Surg Oncol Volume: 129 Page(s): 112 - 116
    01/01/2024 Authors: Shvygin A; Manning-Geist BL; Sonoda Y
  • Molecular subtyping in endometrial cancer: A promising strategy to guide fertility preservation.
    Gynecol Oncol Volume: 179 Page(s): 180 - 187
    12/01/2023 Authors: Dagher C; Manning-Geist B; Ellenson LH; Weigelt B; Rios-Doria E; Barry D; Abu-Rustum NR; Leitao MM; Mueller JJ
  • Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study.
    Gynecol Oncol Volume: 176 Page(s): 69 - 75
    09/01/2023 Authors: Sia TY; Manning-Geist BL; Ehmann S; Lavery JA; Luardo C; Praiss A; Iasonos A; Sonoda Y; Grisham RN; Liu YL
  • The highs and lows of serous ovarian cancer.
    Cancer Volume: 129 Page(s): 2613 - 2620
    09/01/2023 Authors: Grisham RN; Manning-Geist BL; Chui MH
  • Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies.
    Cancer Volume: 129 Page(s): 2004 - 2012
    07/01/2023 Authors: Manning-Geist BL; Kahn RM; Nemirovsky D; Girshman J; Laibangyang A; Gordhandas S; Iasonos A; Chui MH; Long Roche K; Zivanovic O
  • Comprehensive analysis of germline drivers in endometrial cancer.
    J Natl Cancer Inst Volume: 115 Page(s): 560 - 569
    05/08/2023 Authors: Gordhandas S; Rios-Doria E; Cadoo KA; Catchings A; Maio A; Kemel Y; Sheehan M; Ranganathan M; Green D; Aryamvally A
  • Beyond the estrogen receptor: In search of predictive biomarkers for low-grade serous ovarian cancer.
    Cancer Volume: 129 Page(s): 1305 - 1307
    05/01/2023 Authors: Grisham RN; Manning-Geist BL; Chui MH
  • Validation of claims-based algorithms to identify non-live birth outcomes.
    Pharmacoepidemiol Drug Saf Volume: 32 Page(s): 468 - 474
    04/01/2023 Authors: Zhu Y; Bateman BT; Hernandez-Diaz S; Gray KJ; Straub L; Reimers RM; Manning-Geist B; Yoselevsky E; Taylor LG; Ouellet-Hellstrom R
  • Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management.
    Gynecol Oncol Volume: 170 Page(s): 93 - 101
    03/01/2023 Authors: Liu YL; Manning-Geist BL; Knezevic A; Deng L; Bromberg M; Funt SA; Meisel JL; Zivanovic O; Roche KL; Sonoda Y
  • Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation.
    Int J Gynecol Cancer Volume: 32 Page(s): 1576 - 1582
    12/05/2022 Authors: Manning-Geist B; Gordhandas S; Hodgson A; Zhou QC; Iasonos A; Chi DS; Ellenson L; Aghajanian CA; Abu-Rustum NR; Leitao M
  • MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma.
    Clin Cancer Res Volume: 28 Page(s): 4456 - 4465
    10/14/2022 Authors: Manning-Geist B; Gordhandas S; Liu YL; Zhou Q; Iasonos A; Da Cruz Paula A; Mandelker D; Long Roche K; Zivanovic O; Maio A
  • Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.
    Clin Cancer Res Volume: 28 Page(s): 4302 - 4311
    10/03/2022 Authors: Manning-Geist BL; Liu YL; Devereaux KA; Paula ADC; Zhou QC; Ma W; Selenica P; Ceyhan-Birsoy O; Moukarzel LA; Hoang T
  • Demographic shifts associated with implementation of evidence-based guidelines for ovarian conservation in patients with endometrioid endometrial cancer.
    Int J Gynecol Cancer Volume: 32 Page(s): 1141 - 1146
    09/06/2022 Authors: Manning-Geist BL; Rios-Doria E; Aviki EM; Zhou Q; Iasonos A; Abu-Rustum NR; Brown CL; Mueller JJ
  • Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series.
    Int J Gynecol Cancer Volume: 32 Page(s): 1017 - 1024
    08/01/2022 Authors: Sia TY; Manning-Geist B; Gordhandas S; Murali R; Marra A; Liu YL; Friedman CF; Hollmann TJ; Zivanovic O; Chi DS
  • Risk factors for financial toxicity in patients with gynecologic cancer.
    Am J Obstet Gynecol Volume: 226 Page(s): 817.e1 - 817.e9
    06/01/2022 Authors: Aviki EM; Manning-Geist BL; Sokolowski SS; Newman T; Blinder VS; Chino F; Doyle SM; Liebhaber A; Gordhandas SB; Brown CL
  • Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
    Transplant Cell Ther Volume: 28 Page(s): 264.e1 - 264.e9
    05/01/2022 Authors: Williams KM; Pavletic SZ; Lee SJ; Martin PJ; Farthing DE; Hakim FT; Rose J; Manning-Geist BL; Gea-Banacloche JC; Comis LE
  • Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.
    Support Care Cancer Volume: 30 Page(s): 2713 - 2721
    03/01/2022 Authors: Aviki EM; Thom B; Braxton K; Chi AJ; Manning-Geist B; Chino F; Brown CL; Abu-Rustum NR; Gany FM
  • Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer.
    Sci Rep Volume: 12 Page(s): 974
    01/19/2022 Authors: Gordhandas SB; Manning-Geist B; Henson C; Iyer G; Gardner GJ; Sonoda Y; Moore KN; Aghajanian C; Chui MH; Grisham RN
  • Implementation of Evidence-Based Presurgical Testing Guidelines in Patients Undergoing Ambulatory Surgery for Endometrial Cancer.
    JCO Oncol Pract Volume: 18 Page(s): e219 - e224
    01/01/2022 Authors: Aviki EM; Gordhandas SB; Velzen J; Riley M; Manning-Geist B; Rice J; Weiss H; Abu-Rustum NR; Gardner GJ
  • Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer.
    Gynecol Oncol Volume: 164 Page(s): 12 - 17
    01/01/2022 Authors: Manning-Geist BL; Gordhandas SB; Giri DD; Iasonos A; Zhou Q; Girshman J; O'Cearbhaill RE; Zamarin D; Lichtman SM; Sabbatini PJ
  • Diagnosis and management of an endometrial cancer patient with Cowden syndrome.
    Gynecol Oncol Volume: 163 Page(s): 14 - 21
    10/01/2021 Authors: Manning-Geist BL; Gatius S; Liu Y; Gil M; Da Cruz Paula A; Tuset N; Abu-Rustum NR; Aghajanian C; Weigelt B; Matias-Guiu X
  • Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian Cancer.
    Ann Surg Oncol Volume: 28 Page(s): 6705 - 6713
    10/01/2021 Authors: Manning-Geist BL; Sullivan MW; Sarda V; Gockley AA; Del Carmen MG; Matulonis U; Growdon WB; Horowitz NS; Berkowitz RS; Clark RM
  • Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancer.
    Int J Gynecol Cancer Volume: 31 Page(s): 1341 - 1347
    10/01/2021 Authors: Greer A; Gockley A; Manning-Geist B; Melamed A; Sisodia RC; Berkowitz R; Horowitz N; Del Carmen M; Growdon WB; Worley M
  • Predictive validity of American College of Surgeons: National Surgical Quality Improvement Project risk calculator in patients with ovarian cancer undergoing interval debulking surgery.
    Int J Gynecol Cancer Volume: 31 Page(s): 1356 - 1362
    10/01/2021 Authors: Manning-Geist B; Cathcart AM; Sullivan MW; Pelletier A; Cham S; Muto MG; Del Carmen M; Growdon WB; Sisodia RC; Berkowitz R
  • Tertiary cytoreduction for recurrent ovarian carcinoma: An updated and expanded analysis.
    Gynecol Oncol Volume: 162 Page(s): 345 - 352
    08/01/2021 Authors: Manning-Geist BL; Chi DS; Long Roche K; Zivanovic O; Sonoda Y; Gardner GJ; O'Cearbhaill RE; Abu-Rustum NR; Leitao MM
  • Outcomes by Race Among Women Referred to an Academic Colposcopy Clinic with a Patient Navigation Program.
    J Womens Health (Larchmt) Volume: 30 Page(s): 902 - 909
    06/01/2021 Authors: Alimena S; Manning-Geist B; Pena N; Vitonis AF; Feldman S
  • Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancer.
    Gynecol Oncol Volume: 159 Page(s): 687 - 691
    12/01/2020 Authors: Kanbergs AN; Manning-Geist BL; Pelletier A; Sullivan MW; Del Carmen MG; Horowitz NS; Growdon WB; Clark RM; Muto MG; Worley MJ
  • Use of ablation and ultrasonic aspiration at primary debulking surgery in advanced stage ovarian, fallopian tube, and primary peritoneal cancer.
    Int J Gynecol Cancer Volume: 30 Page(s): 1052 - 1057
    07/01/2020 Authors: Li S; Manning-Geist B; Gockley A; Ramos A; Sisodia RC; Del Carmen M; Growdon WB; Horowitz N; Berkowitz R; Worley M
  • Validation of algorithms to identify adverse perinatal outcomes in the Medicaid Analytic Extract database.
    Pharmacoepidemiol Drug Saf Volume: 29 Page(s): 419 - 426
    04/01/2020 Authors: He M; Huybrechts KF; Dejene SZ; Straub L; Bartels D; Burns S; Combs DJ; Cottral J; Gray KJ; Manning-Geist BL
  • Trends in Patient Demographics and Diagnostic Yield at an Academic Colposcopy Clinic From 2008 to 2018.
    J Low Genit Tract Dis Volume: 24 Page(s): 178 - 183
    04/01/2020 Authors: Manning-Geist BL; Davis M; Vitonis AF; Feldman S
  • A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Am J Obstet Gynecol Volume: 221 Page(s): 326.e1 - 326.e7
    10/01/2019 Authors: Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
  • Tubo-ovarian abscesses in postmenopausal women: Clinical presentation and outcomes.
    Maturitas Volume: 125 Page(s): 20 - 26
    07/01/2019 Authors: Gockley AA; Manning-Geist BL; Boatin AA; Gu X; Cohen S
  • Sexual Assault in Ethiopian Contexts: Data From a Large Sample of Women and Girls Presenting at Two Hospital-Based, Limited-Resource Sexual Assault Treatment Clinics.
    Violence Against Women Volume: 25 Page(s): 1074 - 1095
    07/01/2019 Authors: Murphy BA; Manning-Geist B; Conrad A; Chao SJ; Desalegn D; Richards A; Borovali M; Sexton S; Goedken J
  • Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
    Gynecol Oncol Volume: 153 Page(s): 63 - 67
    04/01/2019 Authors: Manning-Geist BL; Alimena S; Del Carmen MG; Goodman A; Clark RM; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
  • Learning in a High-Stress Clinical Environment: Stressors Associated with Medical Students' Clerkship Training on Labor and Delivery.
    Teach Learn Med Volume: 31 Page(s): 385 - 392
    01/01/2019 Authors: Johnson NR; Pelletier A; Chen X; Manning-Geist BL
  • Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery?
    Gynecol Oncol Volume: 150 Page(s): 233 - 238
    08/01/2018 Authors: Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
  • Pediatric Granular Cell Tumors of the Vulva: A Report of 4 Cases and a Review of the Literature.
    J Pediatr Adolesc Gynecol Volume: 31 Page(s): 311 - 314
    06/01/2018 Authors: Manning-Geist BL; Perez-Atayde AR; Laufer MR
  • Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Gynecol Oncol Volume: 147 Page(s): 250 - 256
    11/01/2017 Authors: Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
  • The Impact of Diabetes Mellitus on Wound Healing in Breast Reconstruction.
    Ann Plast Surg Volume: 78 Page(s): 260 - 263
    03/01/2017 Authors: Hart A; Funderburk CD; Chu CK; Pinell-White X; Halgopian T; Manning-Geist B; Carlson G; Losken A
  • Preliminary results of a phase II trial of montelukast for the treatment of Bronchiolitis obliterans syndrome after HSCT and implications for immunobiology of disease
    Volume: 47 Page(s): S61 - S61
    04/01/2012 Authors: Williams K; Pavletic S; Lee S; Hakim F; Mitchell S; Manning-Geist BL; Gea-Banacloche J; Comis L; Cowen E; Baird K
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements